- Home
- MTEN vs VYNE Comparison
MTEN vs VYNE Comparison
Compare MTEN & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- VYNE
- Stock Information
- Founded
- MTEN 2015
- VYNE 2003
- Country
- MTEN China
- VYNE United States
- Employees
- MTEN N/A
- VYNE N/A
- Industry
- MTEN Building Products
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- VYNE Health Care
- Exchange
- MTEN Nasdaq
- VYNE Nasdaq
- Market Cap
- MTEN 35.7M
- VYNE 41.9M
- IPO Year
- MTEN 2024
- VYNE 2018
- Fundamental
- Price
- MTEN $5.79
- VYNE $2.49
- Analyst Decision
- MTEN
- VYNE Strong Buy
- Analyst Count
- MTEN 0
- VYNE 2
- Target Price
- MTEN N/A
- VYNE $6.88
- AVG Volume (30 Days)
- MTEN 21.1K
- VYNE 70.8K
- Earning Date
- MTEN 02-15-2025
- VYNE 11-07-2024
- Dividend Yield
- MTEN N/A
- VYNE N/A
- EPS Growth
- MTEN N/A
- VYNE N/A
- EPS
- MTEN 0.13
- VYNE N/A
- Revenue
- MTEN $9,136,855.00
- VYNE $493,000.00
- Revenue This Year
- MTEN N/A
- VYNE $28.30
- Revenue Next Year
- MTEN N/A
- VYNE N/A
- P/E Ratio
- MTEN $44.58
- VYNE N/A
- Revenue Growth
- MTEN 18.30
- VYNE 39.27
- 52 Week Low
- MTEN $1.81
- VYNE $1.57
- 52 Week High
- MTEN $9.87
- VYNE $3.43
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- VYNE 40.82
- Support Level
- MTEN N/A
- VYNE $2.34
- Resistance Level
- MTEN N/A
- VYNE $2.69
- Average True Range (ATR)
- MTEN 0.00
- VYNE 0.19
- MACD
- MTEN 0.00
- VYNE -0.04
- Stochastic Oscillator
- MTEN 0.00
- VYNE 13.79
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.